Showing results (1-10 of 501) with videos related to

Sort By:
Pageof 51
Oral and Maxillofacial Surgery Clinics of North America|March 24, 2024
Pediatric Orbital and Skull Base PathologyDominic Nistal, Amy Lee, Jacob Ruzevick
Journal of Neurosurgery. Case Lessons|March 3, 2025
Intraoperative venous air embolism during endoscopic transsphenoidal surgery: recommendations for management. Illustrative caseThomas Hanks, Spencer Raub, Kyly Hiatt, et al.
Journal of Neurological Surgery. Part B, Skull Base|May 7, 2026
Pituitary Stalk Lesion Sampling by Transsphenoidal Posterior Lobe Biopsy: A Case SeriesKyly Hiatt, Zachary A Abecassis, Jessica Eaton, et al.
Neurosurgical Review|November 16, 2013
Imaging changes following stereotactic radiosurgery for metastatic intracranial tumors: differentiating pseudoprogression from tumor progression and its effect on clinical practiceJacob Ruzevick, Lawrence Kleinberg, Daniele Rigamonti
Immunotherapy|February 19, 2013
Vaccine strategies for glioblastoma: progress and future directionsChristopher Jackson, Jacob Ruzevick, Henry Brem, et al.
Neurosurgery Clinics of North America|July 4, 2012
Clinical trials with immunotherapy for high-grade gliomaJacob Ruzevick, Christopher Jackson, Jillian Phallen, et al.
Oncotarget|December 21, 2020
Advances in meningioma genomics, proteomics, and epigenetics: insights into biomarker identification and targeted therapiesAhmad A Nazem, Jacob Ruzevick, Manuel J Ferreira
Neurosurgery Clinics of North America|July 4, 2012
Potential role for STAT3 inhibitors in glioblastomaChristopher Jackson, Jacob Ruzevick, Anubhav G Amin, et al.
International Medical Case Reports Journal|March 31, 2025
Case Report: Portable X-Ray Guided Blood Patch in Treating Post Dural Puncture Headache Status Post Intrathecal Pump PlacementMark Li, Dominic Nistal, Ryu Komatsu, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 10, 2021
WHO grade III meningioma: De novo tumors show improved progression free survival as compared to secondary progressive tumorsJacob Ruzevick, Alec Gibson, Philip Tatman, et al.
Pageof 51